U.S. Colorectal Cancer Screening Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
U.S. Colorectal Cancer Screening Market is Segmented By Test Type (Fecal Immunochemical Test (FIT), Guaiac-based Fecal Occult Blood Test, Stool DNA Te....
Competitive overview of U.S. Colorectal Cancer Screening Market
Major Players operating in the U.S. colorectal cancer screening market include Polymedco Inc., Eiken Chemical Co. Ltd., Sysmex Corporation, Quidel Corporation, Novigenix SA, Hemosure Inc., Exact Sciences Corp., Epigenomics Inc., Olympus Corporation, Clinical Genomics Technologies Pty Ltd., Abbott, F. Hoffmann-La Roche Ltd, Siemens Healthineers, Koninklijke Philips N.V., Thermo Fisher Scientific Inc., Illumina, Inc., Myriad Genetics Inc., QIAGEN, Merck KGaA
U.S. Colorectal Cancer Screening Market Leaders
- Polymedco Inc.
- Eiken Chemical Co. Ltd.
- Sysmex Corporation
- Quidel Corporation
- Novigenix SA
*Disclaimer: Major players are listed in no particular order.
U.S. Colorectal Cancer Screening Market - Competitive Rivalry, undefined
U.S. Colorectal Cancer Screening Market
Market Consolidated
(Dominated by major players)
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
(Highly competitive with lots of players.)
*Source: Coherent Market Insights